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Abstract Chronic pain is supported by sterile inflammation
that induces sensitisation of sensory neurons to ambient stimuli
including extracellular ATP acting on purinergic P2X receptors.
The development of in vitro methods for drug screening would
be useful to investigate cell crosstalk and plasticity mechanisms
occurring during neuronal sensitisation and sterile neuroinflam-
mation. Thus, we studied, at single-cell level, membrane pore
dilation based on the uptake of a fluorescent probe following
sustained ATP-gated P2X receptor function in neurons and non-
neuronal cells of trigeminal ganglion cultures from wild-type
(WT) and R192Q CaV2.1 knock-in (KI) mice, a model of famil-
ial hemiplegic migraine type 1 characterised by neuronal sensi-
tisation and higher release of soluble mediators. In WTcultures,
pore responses weremainly evoked byATP rather than benzoyl-
ATP (BzATP) and partly inhibited by the P2X antagonist TNP-
ATP. P2X7 receptors were expressed in trigeminal gangliamain-
ly by non-neuronal cells. In contrast, KI cultures showed higher
expression of P2X7 receptors, stronger responses to BzATP, an
effect largely prevented by prior administration of CaV2.1
blockerω-agatoxin IVA, small interfering RNA (siRNA)-based
silencing of P2X7 receptors or the P2X7 antagonist A-804598.
No cell toxicity was detected with the protocols. Calcitonin
gene-related peptide (CGRP), a well-known migraine mediator,
potentiated BzATP-evoked membrane permeability in WT as
well as R192Q KI cultures, demonstrating its modulatory role
on trigeminal sensory ganglia. Our results show an advanta-
geous experimental approach to dissect pharmacological prop-
erties potentially relevant to chronic pain and suggest that CGRP
is a soluble mediator influencing purinergic P2X pore dilation
and regulating inflammatory responses.













Chronic pain is characterised by abnormal crosstalk between
neuronal and non-neuronal cells governed by altered levels of
soluble inflammatory pain mediators, such as cytokines, calcito-
nin gene-related peptide (CGRP) and ATP [1]. These mediators
result in neuronal sensitisation due to persistent changes in gan-
glion environment, inducing tissue remodelling and creating new
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pharmacological properties via new receptor synthesis and as-
sembly, cell recruitment and neuroinflammation. Recent evi-
dence suggests that in chronic pain, ATP-gated P2X receptors
play a pivotal role in triggering and supporting these phenomena
[2, 3]. Considering the heterogeneous expression of ATP-gated
receptors in neurons and non-neuronal cells [4, 5], the outcome
of purinergic signalling is likely to depend on the time course of
receptor activity, in turn related to the tissue context and the
molecularmechanisms at the single-cell level. In particular, when
persistently exposed to an agonist, certain P2X receptors induce
reversible changes in cell membrane permeability characterised
by emergence of large pores through which even large size mol-
ecules can permeate [6, 7]. Although the underlying biophysical
mechanisms are not fully understood, this transient increase in
membrane permeability was first shown for P2X7 receptors [8]
and later for P2X2 and P2X4 receptors [9, 10]. The current
hypothesis is that this process may be essential for sustaining
acute inflammation and its further amplification. Interestingly,
pore dilation can be measured at the single-cell level because
the strong permeability enables measurement of inflow of fluo-
rescent probes [10]. Furthermore, expression and function of
pore-forming receptors in different conditions may vary as out-
come of different pathophysiological conditions and molecular
mechanisms [11].
Our previous work was concerned with R192Q CaV2.1
knock-in mice (R192Q KI), which express voltage-gated
CaV2.1 Ca
2+ channels containing α1A subunits harbouring the
R192Q missense mutation that leads to familial hemiplegic mi-
graine type 1 (FHM-1) in patients [12, 13]. Thismodel suggests a
direct link between mutated CaV2.1 channels, potentiated neuro-
nal responses and an inflammatory basal state [14, 15] due to a
larger release of CGRP [16], ATP and TNF-α [17, 18]. The
present study aimed at comparing the occurrence, time course
and intensity of responses of wild-type (WT) and R192Q KI
trigeminal ganglion (TG) cultures. To this end, we decided to
use an experimentally advantageous approach based on fluores-
cence imaging at the single-cell level rather than measuring the
average fluorescent intensity of a cell population. In fact, within a
heterogeneous cell population like the one employed in the pres-
ent study, our method based on pore permeability evoked by
ATP-receptor agonists enabled us to identify responsive cells
on the basis of their morphology and, thus, to investigate cell-




The mouse model of FHM-1, namely the R192Q KI [13], and
their WT littermates were used. All animal procedures were in
accordance with national regulations of animal welfare and
approved by the ethics committee of the International School
for Advanced Studies (SISSA). Genotyping was performed by
PCR as previously reported [13]. Primary cultures of TG ganglia
frommice of 12–14 days were prepared as previously described
[14] and used 24 h after plating. For small interfering RNA
(siRNA) experiments, TG cultures were transfected 24 h after
plating with SMARTpool mouse siP2X7 (5 ′-GGAA
AGAGCCUGUUAUCAG-3′, 5′-UAGCAGAGGUGACG
GAGAA-3′, 5′-UACAUUAGCUUUGCUUUGG-3′, 5′-
GGAUCCAGAGCACGAAUUA-3 ′; GE Healthcare
Dharmacon Inc., Chicago, IL, USA) and used 48 h later. In each
experiment, control cultures were transfected with scramble
RNA and siGLO RISC-free siRNA (GE Healthcare
Dharmacon Inc.) and used to compare responses with treated
cultures.
Pore permeability fluorescence assay
Time-lapse in situ imaging of membrane permeability was per-
formed according to standard protocols [6]. Briefly, TG cultures
(plated on 18-mm glass slides) were incubated with ethidium
bromide (EtBr; 5 μg/mL; Sigma-Aldrich, S. Giuliano Milanese,
Italy) for 5 min at room temperature in HBSS buffer (152 mM
NaCl, 5 mMKCl, 1 mMMgCl2, 2 mMCaCl2, 10 mM glucose,
10 mM HEPES; pH 7.4). ATP (0.01, 0.1 or 1 mM), the non-
hydrolysable ATP analog α,β-methylene ATP (α,β-meATP;
100 μM) and the P2X7 receptor agonist 2′,3′-O-(4-
benzoylbenzoyl)-ATP (BzATP; 300 μM) were obtained from
Sigma-Aldrich and were added to the cultures to evoke mem-
brane permeability and EtBr uptake. In certain experiments, TG
cultures were pre-incubated (15 min) with the P2X antagonist
TNP-ATP (25 μM, Sigma-Aldrich; IC50[P2X7] > 30 μM) [5];
P2X7 receptor antagonist A-804598 (100 nM; Tocris
Biosciences, Bristol, UK; IC50[P2X7] = 100 nM) [19]; or the
P/Q-type CaV2.1-specific channel blocker ω-agatoxin IVA
(400 nM; 15 h; Tocris Biosciences) [14]. Control experiments
were performed in parallel on the same day and used for statis-
tical comparison.
Cytotoxicity developing during the pore permeability fluo-
rescence assay [20] was quantified by counting pyknotic cells
in control conditions and after 1 or 24 h from 1-h-long stim-
ulation with ATP (1 mM) or BzATP (300 μM) as shown in
Suppl. Fig. 1 a, b (n = 3).
Fluorescence microscopy images (rate 1/min) were acquired
for a total of 40 min in time-lapse mode with a Nikon Eclipse Ti
fluorescence microscope and Nikon Elements software (Nikon
Instruments Europe, Amsterdam, The Netherlands). For post-
acquisition analysis of morphologic parameters and cell
counting of neuronal and non-neuronal responding cells, each
recording was accompanied by two series of phase-contrast and
fluorescence microscopy images acquired at the beginning and
the end of the recording (as exemplified in Suppl. Fig. 2a, b).
Nuclear labelling with fluorescent probe Hoechst 33342
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identified single cells in which a region of interest (ROI) was
used to quantify fluorescence intensity in arbitrary units (AU)
with ImageJ software (time-series analyser module; NIH,
Bethesda, MA, USA). Since the basal rise in ROI fluorescence
was linear (in the absence of agonists, F0; Suppl. Fig. 2c), in
each experiment, fluorescence values during the first 10 min
were used to extrapolate the slope of the basal time/
fluorescence plot (as shown in Suppl. Fig. 2d) subsequently
subtracted from the data shown in Figs. 1, 2, 4, 5 and 6.
Average of single-cell fluorescence intensity values (Fm) evoked
by the agonists was then normalised to baseline values
(Fm − F0) and plotted as function of time (Fm − F0/min) using
Microsoft Office Excel. The percentage of responding cells was
calculated as the number of responding ROIs over the total
number of nuclei (probed with Hoechst 33342), counted at the
end of the recording (taken as 100%). Summary of the number
of analysed cells is included in figure legends, Tables 1 and 2
and Suppl. Tables 1 and 2.
Immunofluorescence
experiments
TG ganglia and cultures were processed for immunofluores-
cence as previously described [14] with minimal modifica-
tions. Samples were incubated with a blocking buffer com-
posed by 10% horse serum and 0.1% Triton X-100 in phos-
phate buffer for 1 h and incubated with anti-P2X7 antibodies
(1:500; Alomone Labs, Jerusalem, Israel), anti-glutamine syn-
thase (1:150; Millipore, Milan, Italy), anti-CD11b (1:100,
Sigma-Aldrich), F4/80 antibodies (1:100, Sigma-Aldrich)
and anti-β-tubulin 3 (1:1000; Sigma-Aldrich) antibodies for
2 h at room temperature in the same buffer. Signal was detect-
ed with AlexaFluor 488- or 594-conjugated secondary anti-
bod i e s (1 :500 ; The rmoF i she r Sc i en t i f i c Inc . ) .
Immunofluorescence experiments with anti-P2X7 receptors
(1:100; Alomone) were tested for specificity in mouse macro-
phage cell line J774.2 and in P2X7-negative HEK293 cells
a b
c d
Fig. 2 Effect ofω-agatoxin IVA onmembrane pore permeability evoked
by BzATP. a, bMembrane pore permeability of TG cultures fromWT (a)
or R192QKImice (b) after application of BzATP (300 μM) alone or after
pre-treatment with ω-agatoxin IVA (Aga; 400 nM, 15 h). Data are
expressed as percent of mean of maximum fluorescence intensity values
of untreated control culture after application of BzATP (300μM, 30min);
n = 3. cHistograms quantify the fluorescence intensity (expressed as% of
response of WT untreated control cultures at 40 min, taken as 100%,
dashed line) inWTand KI cultures, in standard control conditions or after
pre-treatment with Aga (400 nM, 15 h) as indicated; n = 3, *p = 0.003
(WT vs KI), **p = 0.001 (KI vs KI Aga). d Percent of responding cells
counted after 20 min from beginning of the recording experiments, cal-





Fig. 1 Fluorescence recordings of membrane pore permeability in TG
cultures. a, b Imaging recordings of EtBr fluorescence intensity (in
arbitrary units, AU) of TG cultures from WT (a) or R192Q KI mice (b),
to quantify the membrane pore permeability at the single-cell level during
the time (min) after application of ATP (0.01, 0.1 or 1 mM, as indicated).
ATP was applied after 10 min from the beginning of the recordings
(arrows). In insets, histograms quantify the percent of responding cells
in each condition, counted on the total number of cells after 20 min from
the beginning of the recordings. For WT: n = 3–6 experiments; with 919,
2711 or 2812 analysed cells for 0.01, 0.1 or 1 mM ATP, respectively. For
KI: n = 3–4; with 1068, 557 or 535 analysed cells for 0.01, 0.1 or 1 mM
ATP, respectively; *p = 0.001 (0.1 vs 1 mM ATP, both for WT and KI
samples). c, d As before, after application of BzATP (300 μM, arrows);
n = 5, for a total of 6825 analysed cells for WT and 3782 for KI samples
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(Suppl. Fig. 2e). Nuclei were counterstained with Hoechst
33342 (1:1000; Sigma-Aldrich). Samples were mounted on
glass slides with anti-fading reagent (Vector Laboratories,
Burlingame, CA, USA) and analysed with the Nikon fluores-
cence microscope.
Western blot
Efficiency of siP2X7 in TG cultures was measured byWestern
blotting. Forty-two hours after application of siRNA (72 h
after plating), protein extracts were prepared from TG cultures
in 30 mM Tris-HCl (pH 7.5), 150 mM NaCl and 1% CHAPS
plus protease inhibitors (Sigma-Aldrich). Extracts were kept
on ice for 30min and centrifuged at 6000×g for 5 min. Twenty
micrograms of protein extract was loaded on a SDS-
polyacrylamide gel (10%) and transferred to nitrocellulose
membranes. Membranes were incubated with anti-P2X7 anti-
bodies (1:500; Alomone Labs). Signals were detected with an
enhanced chemiluminescence light system (ECL; Amersham,
Uppsala, Sweden), quantified with Alliance UVtech
(Cambridge, UK) and normalised with respect to the level of
β-actin (1:500; Sigma-Aldrich), which was used as gel load-
ing control.
Data analysis and statistics
Data are expressed as mean ± standard error of the mean
(SEM), where n indicates the number of experiments.
Statistical analysis was performed using the nonparametric
Mann-Whitney rank sum test or t test using software directed
analysis (Sigma Plot & Sigma Stat, Chicago, IL, USA). A p
value of < 0.05 was accepted as indicative of a statistically
significant difference.
Results
ATP (or synthetic agonists) induced pore permeability
change in TG cultures from WTand R192Q KI mice
Previous studies have characterised the mouse TG primary
cultures [21]. In particular, while sensory neurons are a minor-
ity component either in situ or in culture, a variety of non-
neuronal cells is observed that comprise a large population of
macrophages, satellite glial cells and fibroblasts [4, 16, 18]. In
the present experiments, we investigated the membrane per-
meability of TG culture cells to EtBr. In WT cultures, appli-
cation of ATP (0.01, 0.1 or 1 mM, arrows in Fig. 1a) enhanced
single-cell fluorescence in a dose-dependent manner. The
number of ATP-responsive cells also grew in relation to the
concentration of ATP and was significantly different between
Table 1 Fluorescence responses of WT and R192Q KI TG cultures to ATP
ATP WT KI WT KI WT KI
0.01 mM 0.1 mM 1 mM
% responders[20 min] 0.5 ± 0.48 2.4 ± 0.75 1.5 ± 0.8 2.5 ± 0.5 5.1 ± 1.4 13.6 ± 0.7***
Fluorescence intensity 20 min 2.6 ± 0.5 0.5 ± 0.3 0 ± 0.5* 1.7 ± 0.06* 4 ± 0.4 3.3 ± 1
Fluorescence intensity 40 min 3.2 ± 1.9 6.5 ± 2.9 10.4 ± 1.7 7.4 ± 1.3 19.1 ± 1.5 33.7 ± 1.7**
Rate 0.4 0.3 0.7 0.3 1.3 1.7
Latency 37 19.8 25 21 17 19.4
Time-to-peak/to-plateau 55 55 55 30 30 31
No. experiments 3 3 6 4 6 4
Total no. of cells 919 1068 2711 557 2812 535
Intensity is measured after 20 or 40 min from the beginning of the recordings or at peak and is expressed as AU values. Latency to a response, rate, time-
to-peak and time-to-plateau are expressed in minutes
*p = 0.001 (0.1 mM vs 1 mM ATP, both for WT and KI samples); **p = 0.043 (1 mMWT vs KI); ***p = 0.001 (%WT vs KI responding cells, tested
with 1 mM ATP)
Table 2 Fluorescence responses of WT and R192Q KI TG cultures to
BzATP
BzATP = 300 μM WT KI
% responders[20 min] 4.3 ± 0.85 10 ± 1.6***
Fluorescence intensity after 20 min 8.7 ± 1.1 20 ± 2.4*
Fluorescence intensity after 40 min 28.7 ± 6.7 46 ± 5**
Rate 0.5 1
Latency 15 10
Time to peak/plateau 55 55
No. experiments 5 5
Total no. of cells 7161 5955
Responders are expressed as percentage of total number of cells. Intensity
ismeasured after 20min from initial of the recording or at peak, expressed
in AU values
*p = 0.005 (WT vs KI); **p = 0.001 (WT vs KI); ***p = 0.008 (%WT vs
KI responding cells)
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0.1 and 1 mM (n = 4–6; p = 0.001; Fig. 1a, insets). The
response latency was dependent on the ATP concentration
used in the assay; on average, the latency was 25 min for
0.1 mM and 17 min for 1 mM ATP (Table 1). In R192Q KI
cultures, after 20 min from beginning of the recordings, 1 mM
ATP induced a stronger response than 0.1 mMATP inWTand
R192Q KI cultures (n = 4–6 experiments; p = 0.001; Fig. 1b),
and the number of cells responsive to 1 mM ATP was also
significantly (p = 0.001) larger in R192QKI cultures thanWT
(Table 1). The data sets of the number of responders measured
after 20 min and at the end of the recording are included in
Suppl. Table 1.
Although ATP is a natural agonist of P2 receptors, its ability
to bind and activate awide population of P2X and P2Y receptors
makes it difficult to assess the actual receptor contribution from
the obtained fluorescence signals. The P2X receptor first report-
ed for its ability to generate pore dilation with increased mem-
brane conductance is the P2X7 subtype. Thus, we next explored
the effect of the synthetic P2X7 receptor agonist BzATP
(Table 2). In WT cultures, BzATP (300 μM) evoked a fluores-
cence signal that rapidly grew faster in 283 out of 6825 total
analysed cells to reach a level of fluorescence intensity compa-
rable with the one produced by 1 mM ATP in the same time
interval (in 143/2812 cells; Fig. 1a, c). In R192Q KI cultures,
fluorescence intensity responses to BzATP were significantly
stronger already after 20 min from the beginning of the record-
ings (8.7 ± 1.1 in WT and 20 ± 2.4 in KI, n = 5, p = 0.005) that
further increased after 40 min (28.7 ± 6.7 in WT and 46 ± 5 in
KI; Fig. 1c, d and Table 2). The fluorescence uptake following
BzATP application was observed in a significantly larger num-
ber of responding R192Q KI cells (389/3782 cells) than in WT
(282/6825 cells; n = 5, p = 0.008; Fig. 1c, d, insets). The number
of responding cells to BzATP was growing during the time
course, as shown in Suppl. Table 1. Any cytotoxicity originating
from the pharmacological treatments was quantified in control
conditions and after 1 or 24 h from 1-h-long application of ATP
(1mM) or BzATP (300μM): data are shown in Suppl. Fig. 1a, b
(n = 3). The EtBr uptake was mainly observed in spindle-like
glial cells and in flat, large inflammatory cells immunopositive
for the macrophage markers F4/80 or CD11b (Suppl. Fig. 2a, b;
[18]). The EtBr fluorescence uptake was observed also in a
minority of neurons (15% of WT and 18% KI neurons; calcu-
lated on 659 WT and 466 KI neurons; n = 9–6 experiments).
We cannot exclude that non-P2X7 receptors (like P2X2
receptors) were involved in this phenomenon. For instance,
since KI cultures constitutively express potentiated P2X3 re-
ceptors [14], we appliedα,β-meATP (agonist of P2X1, P2X2/
3 and P2X3 receptors [5]) and we measured the time course of
pore formation (Suppl. Fig. 3). After 10min fromα,β-meATP
application (100 μM), we observed a fluorescence signal in a
small number of WT cells (6/418; n = 3). This phenomenon
was further characterised by 20 min time to plateau and sub-
stantially smaller in R192Q KI cultures, though present in a
larger number of cells (131/949; n = 4; p = 0.026; Suppl. Fig.
3). The number of the cells responsive to α,β-meATP did not
change further during the time course (Suppl. Table 1). These
experiments demonstrated a significantly early response in a
larger number of α,β-meATP responding cells in KI with
respect to WT cultures.
The enhanced R192Q KI fluorescence profile was
normalised by the P/Q-type blocker ω-agatoxin IVA
The difference in fluorescence responses between WT and
R192Q KI cultures might be correlated to sensory neuron
sensitisation and/or the neuroinflammatory state previously
reported for R192Q KI TG cultures [14, 18]. We, therefore,
tested the effect of the P/Q-type CaV2.1 blocker ω-agatoxin
IVA (400 nM, 15 h) on fluorescence signals induced by
BzATP (300 μM). ω-Agatoxin IVA had no significant effect
on background fluorescence intensity ofWTcultures nor did it
change responses to BzATP (Fig. 2a, c). However, in R192Q
KI cultures pre-treated with ω-agatoxin IVA, the response to
BzATP was significantly smaller compared to untreated con-
trol (p = 0.001 for KI Aga vs KI control; Fig. 2b, c) and
generated by a lower number of cells (4/322; p = 0.004;
Fig. 2d), while the toxin pre-incubation did not significantly
alter the number of responding cells in WT cultures (24/377;
Fig. 2d). These experiments suggest that responses evoked by
BzATP on R192Q KI cultures were strongly up-regulated as a
consequence of the R192Q CaV2.1 channel mutation.
P2X7 receptor expression in TG tissue and cultures
from WTor R192Q KI mice
Next, we investigated whether differences between WT and
R192QKI cultures observed after application of BzATP could
be attributed to differences in the expression of P2X7 recep-
tors by employing fluorescence microscopy experiments and
specific anti-P2X7 receptor antibodies, validated in control
experiments (Suppl. Fig. 2e). In TG tissue in situ, P2X7 re-
ceptor immunoreactive cells were more abundant (p = 0.006)
in R192Q KI than WT mice, as the signal was mainly local-
ised to fibre regions (n = 3; Fig. 3a). In TG cultures, P2X7
receptor staining was observed in few non-neuronal cells (Fig.
3b) as previously reported [22–24], and the number of P2X7
positive cells was similar in R192Q KI culture and typical of
satellite glial cells counterstained with glutamine synthase
(Fig. 3b).
We then explored the pharmacological profile of the
BzATP effect. For this purpose, we first used the broad-
spectrum P2X antagonist TNP-ATP, which at 25 μM concen-
tration (15 min) had little effect on the response to BzATP
(300 μM) by WT or R192Q KI cultures (Fig. 4a, b), albeit
the number of responsive cells was lower in R192Q KI cul-
tures (n = 3, p = 0.02; Fig. 4b and Suppl. Table 2). Because
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TNP-ATP lacks subtype receptor selectivity [5], the selective
P2X7 receptor antagonist A-804598 (100 nM, 15 min; [19])
was tested next. As indicated in Fig. 4c, this antagonist had no
significant effect on BzATP-induced responses inWTcultures
(3.9% fluorescence intensity in WT control vs 4.4 ± 0.6% in
WTA-804598-treated cells, in 33/1312 cells; Suppl. Table 2).
However, in R192Q KI cultures, A-804598 decreased the in-
tensity signal elicited by BzATP (8.2 ± 6% in KI control vs
4.1% in KI A-804598-treated cells; n = 4; p = 0.04; Fig. 4d), a
phenomenon associated with a significantly lower number of
responsive cells with respect to untreated control R192Q KI
samples (17/398 A-804598-treated cells; n = 4, p = 0.026;
Fig. 4d and Suppl. Table 2).
We further studied the role of P2X7 receptor expression by
siRNA silencing (siP2X7) in TG cultures (Fig. 5a, b and
Suppl. Fig. 4). Under this condition, the fluorescence signal
evoked by BzATP (300 μM) in WT cultures remained the
same with respect to the signal recorded from cultures treated
with scramble siRNAwith no significant change in the num-
ber of responsive cells (48/1032 siP2X7-treated WT cells,
n = 8; Fig. 5a). In R192Q KI cultures, BzATP evoked a small-
er fluorescence signal after siP2X7 application compared to
control (Fig. 5b) associated with significantly lower number
of cells (17/1087 siP2X7-treated KI cells; n = 8, p = 0.001;
Fig. 5b and Suppl. Table 2), suggesting a substantial contribu-
tion of P2X7 receptors in BzATP-evoked pore formation by
R192QKI samples.Wewonderedwhether other P2X receptor
subtypes might be involved in the fluorescence responses after
siP2X7. Among other pore-forming structures, P2X4 recep-
tors were reported [6], which prompted us to perform P2X4
receptor silencing. Treatment of TG cultures with siP2X4 sig-
nificantly lowered the EtBr uptake and the number of
a
b
Fig. 3 Expression of P2X7 receptors in TG ganglia and cultures. a
Example of fluorescence microscopy photographs of TG ganglia from
WT and R192Q KI mice, stained with anti-P2X7 receptors and neuron-
specific anti-β-tubulin III antibodies, as indicated. Scale bar, 50 μm.
Histograms quantify the P2X7 immunoreactivity inWTand KI TG tissue
per ROI expressed in arbitrary units (AU); n = 3; *p = 0.006. b Example
of fluorescence microscopy photographs of R192Q KI TG cultures,
stained with anti-P2X7 receptors and anti-glutamine synthase (GS) anti-
bodies or with anti-P2X7 receptors and β-tubulin III antibodies. Nuclei
are stained with Hoechst 33342. Scale bar, 20 μm. Histograms quantify
the percent of occurrence of P2X7 receptor immunopositive GS cells in
WTand KI TG cultures which was not significantly different between the
two cell samples; n = 3
a b
c d
Fig. 4 Effect of the antagonists TNP-ATP and A-804598 on pore per-
meability evoked by BzATP. a, b Fluorescence recording profiles during
the time (min) in TG cultures from WT (a) or R192Q KI (b) after appli-
cation of BzATP (300 μM, arrows) alone or in cultures pre-treated with
TNP-ATP (25 μM, 15 min). Histograms (insets) quantify the percent of
responding cells, measured after 20min from beginning of the recordings,
namely in 29/815 WT and 23/705 KI cells; n = 3, *p = 0.016 (KI vs KI
TNP-ATP). c, d Fluorescence recordings quantify pore formation in TG
cultures pre-treated with the P2X7 antagonist A-804598 (100 nM,
15 min); n = 4. Histograms quantify the number of responding cells after
20 min from beginning of recordings. Increased fluorescence uptake was
observed in 33/1312WTand 17/398 KI cells; n = 4, *p = 0.026 (KI vs KI
A80)
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responding cells with respect samples treated with scramble
siRNA (10/297 in WT and 11/502 in KI siP2X4-treated cells;
n = 3, *p = 0.027; Fig. 5c, d).
Functional relevance for migraine mediator signalling
Among different pain mediators, CGRP has been identified as a
major contributor to migraine pain [25]. In fact, ambient CGRP
concentrations are almost doubled in R192Q KI cultures with
respect to WT and membrane depolarisation evokes release of
CGRP more than five times larger by R192Q KI cultures than
by WT ones [16]. CGRP also potentiates P2X3-mediated neu-
ronal responses and P2Y receptor-mediated responses in satellite
glial cells of TG ganglia [16, 26]. In order to test whether CGRP
may influence fluorescence responses triggered by BzATP
(300 μM), TG cultures were pre-treated with CGRP (1 μM,
4 h) before testing. InWTand R192QKI cultures, this treatment
significantly potentiated the fluorescence signal (p = 0.01; Fig.
6a, b), an effect readily observed in WT and KI cultures (Fig.
6c). In addition, inWTsamples treated with CGRP, 68/376 cells
responded to BzATP with pore formation at early time points, a
number that did not grow further (Suppl. Table 2). In R192QKI
samples, CGRP induced a delayed rise in the number of
responding cells (from 52 at early stages to 81 responders at
end points out of a total of 496 KI cells). Application of the
CGRP receptor blocker CGRP8–37 strongly reduced the number
of pore forming cells in R192Q KI cultures (63/597WTcells vs
15/793 KI cells; Fig. 6d) in line with the larger constitutive
release of CGRP by this model.
Discussion
In the present study, we applied the membrane permeability
assay to interrogate the cell-to-cell crosstalk based on activation
of purinergic receptors in primary TG cultures. Notably, fluores-
cent probe uptake, measured in a time-lapse mode at the single-
cell level, provided a useful monitoring of the dynamics of
evoked responses. The different activation profiles detected in
WT and R192Q KI cultures supported the previously demon-
strated alteration in neuro-immune TG context of the KI model
[18]. Hence, the membrane permeability assay was useful to
explore intercellular communication in primary cultures of sen-
sory ganglia evoked by purinergic receptor signalling possibly
relevant to chronic pain conditions.
Purinergic signalling and pore formation
R192Q KI mice express mutated CaV2.1 channels that exhibit
gain of function [13]. As a consequence, this genetic model
shows enhanced excitability of TG neurons [14, 15] and larger
release of neuroinflammatory modulators [16, 18]. However,
the time course and the impact of soluble mediators on
neuron-glia crosstalk or their role in amplifying cell responses
remain incompletely understood. ATP is one of the major
players of the communication between neuronal and non-
neuronal cells acting on various ATP-gated receptors in a
time- and concentration-dependent fashion [27]. ATP gener-
ates early ionic- and G protein-associated signalling [1], as
well as slowly developing changes in membrane permeability
with sustained impact on tissue inflammatory responses [28].
With respect to the latter, membrane pore permeability is
evoked by prolonged activation of ATP receptors expressed
by macrophages [10] and necessary to initiate inflammasome
assembly, exosome release and delayed inflammatory effects
[29]. The relatively long latency of the responses observed in
the present study might imply slow membrane rearrangement
or even indirect effects induced by agonist concentrations act-
ing on multiple targets. It was noteworthy that, under the cur-
rent experimental conditions, we did not detect any significant
cell toxicity. In addition, we observed variable kinetics in the
time course of the responding cells in WT or KI cultures
a b
c d
Fig. 5 siP2X4 or siP2X7 modulates BzATP-evoked fluorescence in TG
cultures. a, bMembrane pore permeability in TG cultures fromWT (a) or
R192Q KI (b) after application of BzATP (300 μM, arrows), after appli-
cation of scrambled siRNA (control) or siP2X7. Histograms (insets)
quantify the percent of responding cells, measured after 20 min from
beginning of recording, i.e. fluorescence uptake was measured in 48/
1032 siP2X7 WT cells and in 17/1087 siP2X7 KI cells; n = 5,
*p = 0.001 (KI vs KI siP2X7). c, d Membrane pore permeability in TG
cultures from WT (c) or R192Q KI (d) after application of BzATP
(300 μM, arrows), after application of scrambled siRNA (control) or
siP2X4. Histograms quantify the percent of responding cells after
20 min from beginning of the recordings, corresponding to 10/297 WT
and 11/502 KI cells; n = 3, *p = 0.027 (KI vs KI siP2X4)
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stimulated with different compounds that might reflect com-
plex phenomena involving crosstalk among different path-
ways and/or cells inducing variations in cell membrane per-
meability to the fluorescent probe.
In WT cultures, a small number of cells (< 10%),
characterised by ATP concentration-dependent pore forma-
tion, comprised a heterogeneous cell population (including
satellite glia and inflammatory cells) likely expressing differ-
ent ATP receptors. In contrast, in R192Q KI cultures, a larger
number of cells responded to ATP application in accordance
with higher inflammatory responses [18]. Furthermore, the
steady-state response in R192Q KI culture was more intense,
suggesting higher expression of P2X receptors mediating the
probe uptake. The fluorescence responses evoked by BzATP
application appeared to differ from the ones induced by ATP,
perhaps outlining a contribution of P2Y receptors in this pro-
cess. A modulatory role of P2Y receptor isoforms has been
proposed [16, 30], although their role in TG cell crosstalk
requires further studies.
P2X7 receptors of TG cultures
The persistent occupancy of agonist binding sites on certain
subtypes of P2X receptors, such as P2X2, P2X4, P2X5 and
P2X7 receptors [31], causes delayed formation of a cation-
permeable pore that allows influx of fluorescent probes.
While the mechanistic details of pore dilation remain unre-
solved and controversial [7], the low-affinity, slowly
desensitising P2X7 receptors are the subtype first reported
with this phenomenon [32]. In TG ganglia, P2X7 receptors
are expressed especially by satellite glia and inflammatory
cells [23], as confirmed in the present study. In R192Q KI
cultures (unlike WT ones), the P2X7-preferential agonist
BzATP-evoked responses prevented by the P/Q-type
(CaV2.1) specific channel blocker ω-agatoxin IVA [14], sug-
gesting that the larger fluorescent probe uptake phenomenon
depended on the overactivity of mutated CaV2.1 channels pre-
sumably priming the ganglion environment. Interestingly, the
P2X7 receptor antagonist A-804598 as well as the large-
spectrum P2X antagonist TNP-ATP had no effect on WT cul-
tures, while they strongly inhibited responses in R192Q KI
cells. Although TNP-ATP also reverses P2X4 receptor-
mediated mechanical allodynia after peripheral nerve injury
[33], the present data with pharmacological antagonists are
broadly consistent with the outcome of P2X7 silencing in
R192Q KI cultures. Our results, therefore, suggest a large
contribution of P2X7 receptor-associated pore-forming mech-
anisms in R192Q KI. However, P2X7 receptors, particularly
in WTcells, were not the sole contributors to the fluorescence
signal. The present results might be accounted for by two
processes, namely the existence of distinct P2X7 and P2X4
receptors or heteromeric complexes made up by a combina-
tion of such subunits. The latter possibility is compatible with
the demonstration that, in inflammatory conditions, P2X4 re-
ceptors expressed in satellite glial cells can contribute to
higher sensitivity to ATP [34]. The present results indicate,
therefore, the novel contribution of P2X4 receptors expressed
by satellite glial cells. In addition, the functional relation be-
tween P2X4 and P2X7 receptors and the occurrence of
heteromeric P2X4/7 receptors has been recently detected in
various tissues [35, 36], though not in TG yet. In HEK cells,
recombinant heteromeric P2X4/7 receptors differentially in-
fluence ATP response, pore formation and fluorescent dye
uptake with respect to expression of P2X7 alone [37–39].
Future experiments are needed to clarify these issues.
Becauseα,β-meATP evokes the release of endogenous ATP
from neurons via a Pannexin 1-mediated mechanism [40], the
application of this agonist induced a fluorescence signal that we
may attribute to activation of a wider P2X receptor population
following by ATP priming. The reason for the smaller effect of
a b
c d
Fig. 6 CGRP modulates membrane pore permeability in TG cultures. a,
bMembrane pore permeability in TG cultures fromWT (a) or R192QKI
(b) after application of BzATP (300 μM, arrows), in standard conditions
(control) or in cultures pre-treated with CGRP (1 μM, 4 h). c Histograms
quantify the fluorescence change (calculated as percentage of control
samples, measured after 40 min from beginning of the recordings) in
controls or after CGRP (1 μM, 4 h) or CGRP8–37 (1 μM, 4 h) treatments.
Dashed line indicatesWTcontrol values, taken as 100%. *p = 0.029 (WT
vsWTCGRP); **p = 0.019 (WT vsKI control samples); #*p = 0.005 (KI
vs KI CGRP); #p = 0.037 (KI CGRP vs KI CGRP8–37), ##p = 0.037 (KI
vs KI CGRP8–37); n = 3. d Histograms quantify responding cells in each
condition, measured after 20 min from beginning of the recordings.
Increased fluorescent probe uptake was observed in 68/376 WT or 52/
496 KI CGRP-treated cells and from 63/597WTor 15/793 KI CGRP8–37-
treated cells; n = 3; *p = 0.007 (WT vsWTCGRP); **p = 0.01 (KI CGRP
vs KI CGRP8–37)
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α,β-meATP on R192Q KI cultures remains unclear and might
be possibly due to a more intense indirect contribution by P2Y
receptors activated (or inactivated) by ATP [16].
Role of CGRP in pore formation activity
Because R192Q KI cultures at baseline express a higher num-
ber of potential pore-forming cells [18] and release cytokines,
ATP and CGRP [16, 18, 40], the overall higher membrane
permeability in R192Q KI trigeminal cultures was consistent
with the expected R192Q KI phenotype. In addition, CGRP,
which is a trigger for migraine pain [41] and neuronal sensiti-
sation [26] via immunomodulatory functions [42], potentiated
fluorescence responses in a wider number of cells in R192Q
KI culture rather than in WT one. The effect of endogenous
CGRP was blocked by the selective inhibitor CGRP8–37, sug-
gesting peptide receptor-mediated responses. These observa-
tions indicate the peptide role over a large population of TG
cells. It is noteworthy that the facilitation of non-neuronal cell
permeability by acutely applied CGRP is the only CGRP-
evoked early effect detected so far in R192Q KI cultures. In
summary, Fig. 7 depicts an idealised scheme for the crosstalk
among sensory neurons, satellite glial cells and immune cells
at the level of R192Q KI TG, involving potentiated CaV2.1
channels, enhanced release of CGRP and facilitation of P2X7
(or P2X7-like) signalling all concurring to the lowering the
threshold for trigeminal pain.
Relevance of functional crosstalk in TG cultures
In conclusion, as a consequence of amplified signalling in
R192Q KI cultures, new molecular mechanisms (e.g. gene
expression, splicing, subunit assembly) might emerge at the
single-cell level to account for distinct pharmacological ef-
fects in R192Q KI in comparison with WT samples. This
changing scenariomight add further complexity to the delicate
balance regulating purinergic responses on the basis of ATP
release, expression of heterogeneous receptor subtypes (with
different affinity for ATP) and efficacy of ATP-hydrolysing
enzymes [2, 43].
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